> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears OsteoRemedies Spectrum GV Hip Spacer
- URL: https://www.fdaweb.com/fda-clears-osteoremedies-spectrum-gv-hip-spacer/
- Published: 2018-11-01T12:00:00.000Z
- Updated: 2026-09-15T00:41:55.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5142727

FDA has cleared an OsteoRemedies 510(k) for the Remedy Spectrum GV Hip Spacer System and Spectrum GV Bone Cement, which are intended to provide surgeons with a broad-spectrum treatment option with both gentamicin and vancomycin. The device is indicated for temporary use (maximum 180 days) as an adjunct to total joint replacement in skeletally mature patients undergoing a two-stage procedure due to a septic process and where gentamicin or gentamicin and vancomycin are the most appropriate antibiotics based on the susceptibility pattern of the infecting micro-organisms, according to the company.